The relationship between MAFLD and CVD in a health check-up Chinese population: a prospective cohort study
MAFLD is associated with a higher risk of CVD, especially in MDO. Classification of MAFLD based on body mass index and metabolic status helps in risk stratification, which will mitigate or prevent the development of CVD.
Authors
- Liang Qiao (ORCID: https://orcid.org/0000-0002-4723-8935)
- Chen Dong (ORCID: https://orcid.org/0000-0003-1183-5364)
- Mengmeng Hou (ORCID: https://orcid.org/0000-0001-9961-8473)
- Wenjing Ni (ORCID: https://orcid.org/0000-0001-5241-2304)
- Yao Dou (ORCID: https://orcid.org/0000-0002-1757-3193)
- Xiwei Yuan (ORCID: https://orcid.org/0000-0002-5257-8782)
- Qiuling Wang (ORCID: https://orcid.org/0000-0002-1066-5909)
- Jiawei Cui (ORCID: https://orcid.org/0000-0003-0310-7551)
- C D Chang
- Yuemin Nan (ORCID: https://orcid.org/0000-0003-4192-099X)
- Jie Li (ORCID: https://orcid.org/0000-0003-0973-8645)
- J Shao (ORCID: https://orcid.org/0009-0009-5498-4782)
- Qi Gu
Institutions
- Hebei Medical University (CN)
- WuXi AppTec (China) (CN)
- Westmead Hospital (AU)
- Third Hospital of Hebei Medical University (CN)
- Hospital of Hebei Province (CN)
- Nanjing Drum Tower Hospital (CN)
- Westmead Institute (AU)
- Westmead Institute for Medical Research (AU)
Publication Details
- Journal
- Therapeutic Advances in Chronic Disease
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/20406223251378867
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00